EUVIMEDEUVIMED entdecken
Crossref

Reply: Thoughts on the clinical translation of dynamic fibrosis risk assessment models in MASLD

Gong Feng, Vincent Wai-Sun Wong, Ming-Hua Zheng

Clinical and Molecular Hepatology · 05.11.2026

DOI: 10.3350/cmh.2026.1248 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical and Molecular Hepatology, online erschienen am 05.11.2026. Verfasst von Gong Feng und 2 weiteren Autor:innen. Beteiligte Einrichtung: School of General Medicine of Xi'an Medical University, Xi'an, China.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • School of General Medicine of Xi'an Medical University, Xi'an, China.
  • Institute of General Practice, Xi'an Medical University, Xi'an, China.
  • Department of Gastroenterology, The First Affiliated Hospital of Xi'an Medical University, Xi'an, China.
  • Research Institute of Rural Medicine in Shaanxi Province, Xi'an Medical University, Xi'an, China.
  • Medical Data Analytics Center, Department of Medicine and Therapeutics, The Chinese University of Hong Kong, China.
  • State Key Laboratory of Digestive Disease, Institute of Digestive Disease, The Chinese University of Hong Kong, Hong Kong, China.

Zitieren

APA

Feng, G., Wong, V. W., & Zheng, M. H. (2026). Reply: Thoughts on the clinical translation of dynamic fibrosis risk assessment models in MASLD. Clinical and Molecular Hepatology. https://doi.org/10.3350/cmh.2026.1248

Vancouver

Feng G, Wong VW, Zheng MH. Reply: Thoughts on the clinical translation of dynamic fibrosis risk assessment models in MASLD. Clinical and Molecular Hepatology. 2026. doi:10.3350/cmh.2026.1248

BibTeX
@article{Feng2026,
  author = {Feng, Gong and Wong, Vincent Wai-Sun and Zheng, Ming-Hua},
  title = {Reply: Thoughts on the clinical translation of dynamic fibrosis risk assessment models in MASLD},
  journal = {Clinical and Molecular Hepatology},
  year = {2026},
  doi = {10.3350/cmh.2026.1248}
}
Kostenlos starten →